查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1784018

全球即時血糖監測市場

Point-of-Care Glucose Testing
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 201 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

預計到 2030 年，全球即時血糖監測市場規模將達到 41 億美元

全球即時血糖監測市場規模預計在2024年達到34億美元，預計2024年至2030年期間的複合年成長率為3.3%，到2030年將達到41億美元。本報告分析的細分市場之一Accu Check Aviva Meter預計將實現4.1%的複合年成長率，並在分析期結束時達到11億美元。 Onetouch Verio Flex細分市場在分析期間內的複合年成長率預計為3.6%。

美國市場規模估計為 9.165 億美元，中國市場預計複合年成長率為 6.4%

預計2024年，美國即時血糖監測市場規模將達9.165億美元。作為世界第二大經濟體，中國市場規模預計到2030年將達到8.194億美元，在2024-2030年的分析期間內，複合年成長率為6.4%。其他值得關注的區域市場包括日本和加拿大，預計在分析期間內，這兩個市場的複合年成長率分別為1.3%和2.5%。在歐洲，預計德國市場的複合年成長率為1.9%。

全球即時血糖監測市場—主要趨勢與促進因素摘要

為什麼即時血糖監測對於糖尿病管理至關重要？

照護現場血糖檢測 (PoC) 在糖尿病管理、急診和重症加護監護中發揮著至關重要的作用，它能夠提供即時血糖值讀數，幫助醫護人員和患者做出即時治療決策。與需要樣本處理時間的傳統實驗室血糖檢測不同，即時血糖儀能夠在醫院、診所、門診甚至家庭環境中快速、現場地監測血糖。

全球糖尿病盛行率的上升是推動即時血糖檢測普及的主要因素之一。根據國際糖尿病聯盟 (IDF) 的數據，全球超過 5.37 億成年人患有糖尿病，預計未來幾年這一數字將大幅成長。有效的血糖監測和血糖控制對於預防低血糖、酮症酸中毒和心血管疾病等併發症至關重要，因此即時血糖檢測已成為糖尿病常規護理的重要組成部分。

自我血糖監測 (SMBG) 設備和持續血糖監測 (CGM) 系統的應用日益廣泛，使糖尿病患者能夠持續追蹤血糖濃度，並相應地調整生活方式和藥物治療。此外，醫院和急診室依靠即時血糖儀快速檢測低血糖和高血糖，確保即時治療性介入並改善患者預後。

科技進步如何改善即時血糖檢測？

由於生物感測器技術、連接解決方案和非侵入性血糖監測技術的進步，PoC 血糖測試市場正在快速發展。

最重要的技術創新之一是無線連接與數位健康解決方案的融合。最新的 PoC 血糖儀相容於藍牙、Wi-Fi 和行動應用程式，可將數據無縫傳輸到電子健康記錄(EHR)、雲端基礎和糖尿病管理應用程式。此功能可實現遠端患者監護(RPM) 和醫病協作，使糖尿病管理更加主動和高效。

另一項突破是無創和微創血糖監測設備的開發。傳統的血糖值檢測需要紮手指，對患者來說既痛苦又不方便。如今，各公司正專注於使用穿戴式生物感測器、汗液血糖檢測以及利用紅外光透過皮膚測量血糖濃度的光學血糖感測器進行無針血糖監測。非侵入性血糖檢測可望透過提高患者依從性和改善使用者體驗，徹底改變糖尿病管理。

持續血糖監測 (CGM) 系統的進步也正在再形成市場。與提供一次性讀數的傳統即時血糖儀不同，CGM 提供即時血糖監測，並附帶趨勢分析以及低血糖或高血糖警報。包括雅培 (FreeStyle Libre)、德康 (Dexcom) (G6 和 G7) 和美敦力 (Guardian Connect) 在內的領先製造商正在不斷改進 CGM 技術，以提供更長的感測器配戴時間、更高的準確性以及胰島素幫浦整合。

此外，人工智慧主導的血糖分析和預測演算法正在提高血糖監測的準確性。機器學習模型現在可以分析血糖趨勢，預測波動，並提供個人化的建議，以調整胰島素劑量、飲食計劃和身體活動。人工智慧驅動的即時血糖檢測解決方案有望減少併發症，改善血糖控制，並支援個人化糖尿病管理。

為什麼醫療保健和居家照護環境中對即時血糖檢測的需求不斷成長？

糖尿病、代謝紊亂和文明病的日益流行，導致醫院、門診和家庭護理機構廣泛採用即時血糖檢測 (PoC) 。

  • 醫院和重症加護應用：醫療機構利用即時血糖檢測快速診斷和管理重症加護病房(ICU)、急診室 (ER) 和手術全期護理中的急性血糖事件。接受手術、創傷護理和化療的患者通常會出現血糖值波動，需要頻繁地進行床邊血糖監測以預防併發症。
  • 自我監測與居家照護：隨著越來越多的人選擇在家中管理糖尿病，對自我血糖監測 (SMBG) 設備的需求也隨之飆升。小巧易用的血糖儀，配備清晰易讀的顯示器、語音輔助功能和雲端基礎追蹤功能，讓居家血糖監測更加便捷，尤其適用於老年人和視障患者。
  • 妊娠糖尿病監測：確診患有妊娠糖尿病 (GDM) 的孕婦需要頻繁監測血糖，以預防母嬰併發症。可攜式、一次性、無線血糖儀在孕產婦護理中日益普及，以支持 GDM 的早期發現和管理。
  • 運動與健身應用：運動員和健身愛好者正在使用即時血糖檢測 (PoC) 和動態血糖監測 (CGM) 來監測運動前後的血糖波動。這一趨勢推動了對穿戴式血糖監測儀的需求，這些監測儀可提供代謝健康和能量最佳化的即時洞察。

遠端醫療和數位健康平台的擴張也促進了即時血糖檢測解決方案的需求成長。許多遠端醫療提供者正在將血糖監測數據與虛擬諮詢相結合，以實現遠距糖尿病管理和高風險患者的早期療育。

哪些因素推動了 PoC 血糖測試市場的成長？

PoC 血糖檢測市場的成長受到技術進步、糖尿病盛行率上升以及消費者對主動醫療保健意識的提高的推動。

  • 糖尿病盛行率上升，慢性病負擔加重：全球糖尿病疫情持續推動即時血糖監測解決方案的需求。糖尿病盛行率的快速成長，尤其是在亞太、拉丁美洲和非洲等新興國家，促使各國政府實施納入即時血糖檢測的國家糖尿病篩檢和預防計畫。
  • 政府和保險機構對糖尿病管理的支持：許多國家正在擴大血糖監測設備的保險覆蓋範圍和報銷政策，使糖尿病患者更容易獲得即時血糖儀和動態血糖監測儀 (CGM)。美國食品藥物管理局 (FDA)、歐洲藥品管理局 (EMA) 和世界衛生組織 (WHO) 等醫療保健組織正在推廣使用連網血糖儀和人工智慧主導的糖尿病管理工具，以改善醫療保健效果。
  • 穿戴式和智慧血糖監測設備日益普及：從傳統血糖儀到智慧動態血糖監測 (CGM) 和生物感測器的轉變正在再形成糖尿病護理。整合胰島素自動給藥功能的穿戴式動態血糖監測 (CGM) 的需求日益成長，尤其是在第 1 型糖尿病和胰島素依賴型 2 型糖尿病患者中。
  • 對微創無痛檢測方法的需求日益成長：隨著患者尋求更少疼痛、更便利、更持續的血糖追蹤方案，非侵入式血糖監測解決方案預計將獲得青睞。基於淚液、汗液和唾液的血糖檢測研究正在蓬勃發展，各大公司正在投資下一代非侵入式血糖感測器。
  • 人工智慧和數據分析在糖尿病護理領域的興起：人工智慧驅動的預測分析、血糖趨勢預測和個人化糖尿病指導正在改變患者和醫療保健提供者管理血糖值的方式。將機器學習演算法整合到即時血糖檢測設備中，有望最佳化治療決策並減少糖尿病相關併發症。

血糖監測技術的持續創新、遠端患者監護的日益普及以及醫療保健和居家環境中應用的不斷擴展，將推動即時血糖檢測市場呈指數級成長。隨著互聯健康解決方案、人工智慧主導的診斷以及以患者為中心的糖尿病管理策略的不斷發展，即時血糖檢測將繼續成為全球個人化、數據主導醫療保健的基石。

部分

產品（Accu Check Aviva Meter、Onetouch Verio Flex、i-STAT、Bayer Contour 血糖監測系統、Freestyle Lite、True Metrix、Accu-Chek Inform II、StatStrip 等）

受訪公司範例

  • Abbott Laboratories
  • ACON Laboratories, Inc.
  • ARKRAY, Inc.
  • Ascensia Diabetes Care Holdings AG
  • Bayer AG
  • Dexcom Inc.
  • EKF Diagnostics Holdings plc
  • F. Hoffmann-La Roche Ltd.
  • iHealth Labs Inc.
  • Insulet Corporation
  • LifeScan Inc.
  • Medtronic plc
  • Nipro Corporation
  • Nova Biomedical
  • Prodigy Diabetes Care, LLC
  • PTS Diagnostics
  • Sanofi SA
  • Terumo Corporation
  • Trividia Health, Inc.
  • Ypsomed Holding AG

人工智慧整合

全球產業分析師利用可操作的專家內容和人工智慧工具改變市場和競爭情報。

Global Industry Analysts 沒有查詢通用的 LLM 或特定於行業的 SLM，而是建立了一個從世界各地的專家收集的內容庫，其中包括影片錄像、BLOG、搜尋引擎研究以及大量的公司、產品/服務和市場數據。

關稅影響係數

全球產業分析師根據公司總部所在國家、製造地和進出口（成品和原始設備製造商）情況預測其競爭地位的變化。這種複雜而多面的市場動態預計將以多種方式影響競爭對手，包括銷貨成本(COGS) 上升、盈利下降、供應鏈重組以及其他微觀和宏觀市場動態。

目錄

第1章調查方法

第2章執行摘要

  • 市場概覽
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 西班牙
  • 俄羅斯
  • 其他歐洲國家
  • 亞太地區
  • 澳洲
  • 印度
  • 韓國
  • 其他亞太地區
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中東
  • 伊朗
  • 以色列
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 其他中東地區
  • 非洲

第4章 比賽

簡介目錄
Product Code: MCP32612

Global Point-of-Care Glucose Testing Market to Reach US$4.1 Billion by 2030

The global market for Point-of-Care Glucose Testing estimated at US$3.4 Billion in the year 2024, is expected to reach US$4.1 Billion by 2030, growing at a CAGR of 3.3% over the analysis period 2024-2030. Accu Check Aviva Meter, one of the segments analyzed in the report, is expected to record a 4.1% CAGR and reach US$1.1 Billion by the end of the analysis period. Growth in the Onetouch Verio Flex segment is estimated at 3.6% CAGR over the analysis period.

The U.S. Market is Estimated at US$916.5 Million While China is Forecast to Grow at 6.4% CAGR

The Point-of-Care Glucose Testing market in the U.S. is estimated at US$916.5 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$819.4 Million by the year 2030 trailing a CAGR of 6.4% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.3% and 2.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 1.9% CAGR.

Global Point-of-Care Glucose Testing Market - Key Trends & Drivers Summarized

Why Is Point-of-Care Glucose Testing Essential in Diabetes Management?

Point-of-care (PoC) glucose testing plays a crucial role in diabetes management, emergency care, and critical care settings, providing immediate blood glucose readings that enable healthcare providers and patients to make real-time treatment decisions. Unlike traditional laboratory-based glucose tests, which require sample processing time, PoC glucose meters allow for rapid, on-the-spot glucose monitoring in hospitals, clinics, ambulatory settings, and even home environments.

The global rise in diabetes prevalence is one of the major factors driving the adoption of PoC glucose testing. According to the International Diabetes Federation (IDF), over 537 million adults worldwide have diabetes, and this number is expected to grow significantly in the coming years. Effective glucose monitoring and glycemic control are critical in preventing complications such as hypoglycemia, ketoacidosis, and cardiovascular diseases, making PoC glucose testing an integral part of routine diabetes care.

The increasing adoption of self-monitoring blood glucose (SMBG) devices and continuous glucose monitoring (CGM) systems has empowered diabetic patients to track their glucose levels frequently and make lifestyle or medication adjustments accordingly. Additionally, hospitals and emergency departments rely on PoC glucose meters for rapid hypoglycemia and hyperglycemia detection, ensuring immediate therapeutic interventions and improved patient outcomes.

How Are Technological Advancements Improving PoC Glucose Testing?

The PoC glucose testing market is rapidly evolving with advancements in biosensor technology, connectivity solutions, and non-invasive glucose monitoring techniques.

One of the most significant innovations is the integration of wireless connectivity and digital health solutions. Modern PoC glucose meters are now equipped with Bluetooth, Wi-Fi, and mobile app compatibility, allowing seamless data transmission to electronic health records (EHRs), cloud-based platforms, and diabetes management applications. This feature enables remote patient monitoring (RPM) and physician-patient collaboration, making diabetes management more proactive and efficient.

Another breakthrough is the development of non-invasive and minimally invasive glucose monitoring devices. Traditional blood glucose testing requires finger-pricking, which can be painful and inconvenient for patients. Companies are now focusing on needle-free glucose monitoring using wearable biosensors, sweat-based glucose detection, and optical glucose sensors that utilize infrared light to measure glucose levels through the skin. Non-invasive glucose testing is expected to revolutionize diabetes management by enhancing patient adherence and improving user experience.

Advancements in continuous glucose monitoring (CGM) systems are also reshaping the market. Unlike traditional PoC glucose meters that provide single-time readings, CGMs offer real-time glucose monitoring with trend analysis and alerts for hypoglycemia or hyperglycemia. Leading manufacturers, such as Abbott (FreeStyle Libre), Dexcom (G6 and G7), and Medtronic (Guardian Connect), are continuously improving CGM technology to offer longer sensor wear, improved accuracy, and integration with insulin pumps.

Additionally, AI-driven glucose analytics and predictive algorithms are enhancing the precision of glucose monitoring. Machine learning models can now analyze glucose trends, predict fluctuations, and provide personalized recommendations for insulin dosing, meal planning, and physical activity adjustments. AI-powered PoC glucose testing solutions are expected to reduce complications, improve glycemic control, and support personalized diabetes management.

Why Is Demand for PoC Glucose Testing Growing Across Healthcare and Homecare Settings?

The increasing prevalence of diabetes, metabolic disorders, and lifestyle-related diseases has led to the widespread adoption of PoC glucose testing in hospitals, outpatient clinics, and homecare settings.

  • Hospital & Critical Care Use: Healthcare facilities utilize PoC glucose testing for rapid diagnosis and management of acute glycemic events in intensive care units (ICUs), emergency rooms (ERs), and perioperative care. Patients undergoing surgery, trauma care, or chemotherapy often experience fluctuations in blood glucose levels, necessitating frequent bedside glucose monitoring to prevent complications.
  • Self-Monitoring & Homecare: The demand for self-monitoring blood glucose (SMBG) devices has surged as more individuals manage diabetes independently at home. Compact, user-friendly glucose meters with easy-to-read displays, voice-assisted functions, and cloud-based tracking have made home-based glucose monitoring more convenient, particularly for elderly and visually impaired patients.
  • Gestational Diabetes Monitoring: Pregnant women diagnosed with gestational diabetes mellitus (GDM) require frequent glucose monitoring to prevent complications for both the mother and baby. The adoption of portable, disposable, and wireless glucose meters in prenatal care is increasing to support early detection and management of GDM.
  • Sports & Fitness Applications: Athletes and fitness enthusiasts are using PoC glucose testing and CGMs to monitor glucose variations before and after workouts. This trend has fueled demand for wearable glucose monitors that provide real-time insights into metabolic health and energy optimization.

The expansion of telemedicine and digital health platforms has also contributed to the growing demand for PoC glucose testing solutions. Many telehealth providers now integrate glucose monitoring data with virtual consultations, enabling remote diabetes management and early intervention for high-risk patients.

What Factors Are Driving the Growth of the PoC Glucose Testing Market?

The growth in the PoC glucose testing market is driven by technological advancements, increasing diabetes prevalence, and rising consumer awareness about proactive healthcare.

  • Rising Diabetes Prevalence & Chronic Disease Burden: The global diabetes epidemic continues to fuel demand for real-time glucose monitoring solutions. Developing countries, particularly in Asia-Pacific, Latin America, and Africa, are experiencing a surge in diabetes cases, prompting governments to implement nationwide diabetes screening and prevention programs that incorporate PoC glucose testing.
  • Government & Insurance Support for Diabetes Management: Many countries are expanding insurance coverage and reimbursement policies for glucose monitoring devices, making PoC glucose meters and CGMs more accessible to diabetic patients. Health agencies such as the FDA, EMA, and WHO are promoting the use of connected glucose meters and AI-driven diabetes management tools to improve healthcare outcomes.
  • Increased Adoption of Wearable & Smart Glucose Monitoring Devices: The transition from traditional glucose meters to smart CGMs and biosensors is reshaping diabetes care. The demand for wearable CGMs with automated insulin delivery integration is growing, particularly among Type 1 and insulin-dependent Type 2 diabetic patients.
  • Growing Demand for Minimally Invasive & Painless Testing Methods: Non-invasive glucose monitoring solutions are expected to gain traction as patients seek less painful, convenient, and continuous glucose tracking options. Research into tear, sweat, and saliva-based glucose detection is gaining momentum, with companies investing in next-generation non-invasive glucose sensors.
  • Rise of AI & Data Analytics in Diabetes Care: AI-driven predictive analytics, glucose trend forecasting, and personalized diabetes coaching are transforming how patients and healthcare providers manage blood sugar levels. The integration of machine learning algorithms into PoC glucose testing devices is expected to optimize treatment decisions and reduce diabetes-related complications.

With continuous innovations in glucose monitoring technology, increasing adoption of remote patient monitoring, and expanding applications in healthcare and home settings, the PoC glucose testing market is set for exponential growth. As connected health solutions, AI-driven diagnostics, and patient-centered diabetes management strategies evolve, PoC glucose testing will remain a cornerstone of personalized, data-driven healthcare worldwide.

SCOPE OF STUDY:

The report analyzes the Point-of-Care Glucose Testing market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip, Others)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 42 Featured) -

  • Abbott Laboratories
  • ACON Laboratories, Inc.
  • ARKRAY, Inc.
  • Ascensia Diabetes Care Holdings AG
  • Bayer AG
  • Dexcom Inc.
  • EKF Diagnostics Holdings plc
  • F. Hoffmann-La Roche Ltd.
  • iHealth Labs Inc.
  • Insulet Corporation
  • LifeScan Inc.
  • Medtronic plc
  • Nipro Corporation
  • Nova Biomedical
  • Prodigy Diabetes Care, LLC
  • PTS Diagnostics
  • Sanofi S.A.
  • Terumo Corporation
  • Trividia Health, Inc.
  • Ypsomed Holding AG

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Point-of-Care Glucose Testing - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Global Diabetes Epidemic and Focus on Glycemic Control Propel Demand for Rapid Point-of-Care Glucose Testing
    • Increased Use of POC Glucose Testing in Emergency Rooms and Acute Care Drives Market Expansion
    • Adoption of Bedside Glucose Monitoring in ICUs and Surgical Wards Enhances Patient Safety and Protocol Compliance
    • Home-Based Diabetes Management and Self-Monitoring Support Widespread Use of Compact POC Glucose Devices
    • Technological Innovation in Continuous and Intermittent Glucose Monitoring Blurs Lines With Traditional POC Devices
    • Integration of POC Glucose Test Results With EHR and Mobile Apps Enables Holistic Chronic Disease Management
    • Public Health Campaigns on Early Diabetes Screening Encourage Testing at Pharmacies and Primary Care Clinics
    • Demand for Rapid Testing in Low-Resource and Rural Areas Supports Use of Portable, Battery-Operated Devices
    • Advancements in Non-Invasive and Painless Glucose Testing Technologies Create Disruption Potential
    • Stricter Infection Control and Cross-Contamination Concerns Support Shift to Single-Use, Disposable Strips
    • Reimbursement Policies for POC Glucose Testing Drive Institutional Adoption Across Outpatient Settings
    • Retail Clinics and DTC Health Providers Expand Glucose Testing Accessibility Beyond Traditional Healthcare Facilities
    • Wearable and Smart Glucose Monitors Integrated With POC Capabilities Gain Traction Among Tech-Savvy Patients
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Point-of-Care Glucose Testing Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Point-of-Care Glucose Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Point-of-Care Glucose Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Point-of-Care Glucose Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Accu Check Aviva Meter by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Accu Check Aviva Meter by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Accu Check Aviva Meter by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Onetouch Verio Flex by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Onetouch Verio Flex by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Onetouch Verio Flex by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for i-STAT by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for i-STAT by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for i-STAT by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Bayer Contour Blood Glucose Monitoring System by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Bayer Contour Blood Glucose Monitoring System by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Bayer Contour Blood Glucose Monitoring System by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Freestyle Lite by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Freestyle Lite by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Freestyle Lite by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for True Metrix by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for True Metrix by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for True Metrix by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Accu-Chek Inform II by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Accu-Chek Inform II by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Accu-Chek Inform II by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for StatStrip by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for StatStrip by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for StatStrip by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Others by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Others by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for Others by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Point-of-Care Glucose Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 32: USA Recent Past, Current & Future Analysis for Point-of-Care Glucose Testing by Product - Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Point-of-Care Glucose Testing by Product - Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: USA 15-Year Perspective for Point-of-Care Glucose Testing by Product - Percentage Breakdown of Value Sales for Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 35: Canada Recent Past, Current & Future Analysis for Point-of-Care Glucose Testing by Product - Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Canada Historic Review for Point-of-Care Glucose Testing by Product - Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: Canada 15-Year Perspective for Point-of-Care Glucose Testing by Product - Percentage Breakdown of Value Sales for Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others for the Years 2015, 2025 & 2030
  • JAPAN
    • Point-of-Care Glucose Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Point-of-Care Glucose Testing by Product - Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Point-of-Care Glucose Testing by Product - Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: Japan 15-Year Perspective for Point-of-Care Glucose Testing by Product - Percentage Breakdown of Value Sales for Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others for the Years 2015, 2025 & 2030
  • CHINA
    • Point-of-Care Glucose Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 41: China Recent Past, Current & Future Analysis for Point-of-Care Glucose Testing by Product - Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: China Historic Review for Point-of-Care Glucose Testing by Product - Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: China 15-Year Perspective for Point-of-Care Glucose Testing by Product - Percentage Breakdown of Value Sales for Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others for the Years 2015, 2025 & 2030
  • EUROPE
    • Point-of-Care Glucose Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 44: Europe Recent Past, Current & Future Analysis for Point-of-Care Glucose Testing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 45: Europe Historic Review for Point-of-Care Glucose Testing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: Europe 15-Year Perspective for Point-of-Care Glucose Testing by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Point-of-Care Glucose Testing by Product - Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Point-of-Care Glucose Testing by Product - Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: Europe 15-Year Perspective for Point-of-Care Glucose Testing by Product - Percentage Breakdown of Value Sales for Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others for the Years 2015, 2025 & 2030
  • FRANCE
    • Point-of-Care Glucose Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 50: France Recent Past, Current & Future Analysis for Point-of-Care Glucose Testing by Product - Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: France Historic Review for Point-of-Care Glucose Testing by Product - Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: France 15-Year Perspective for Point-of-Care Glucose Testing by Product - Percentage Breakdown of Value Sales for Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others for the Years 2015, 2025 & 2030
  • GERMANY
    • Point-of-Care Glucose Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 53: Germany Recent Past, Current & Future Analysis for Point-of-Care Glucose Testing by Product - Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Germany Historic Review for Point-of-Care Glucose Testing by Product - Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: Germany 15-Year Perspective for Point-of-Care Glucose Testing by Product - Percentage Breakdown of Value Sales for Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 56: Italy Recent Past, Current & Future Analysis for Point-of-Care Glucose Testing by Product - Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Italy Historic Review for Point-of-Care Glucose Testing by Product - Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: Italy 15-Year Perspective for Point-of-Care Glucose Testing by Product - Percentage Breakdown of Value Sales for Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Point-of-Care Glucose Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 59: UK Recent Past, Current & Future Analysis for Point-of-Care Glucose Testing by Product - Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: UK Historic Review for Point-of-Care Glucose Testing by Product - Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: UK 15-Year Perspective for Point-of-Care Glucose Testing by Product - Percentage Breakdown of Value Sales for Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 62: Spain Recent Past, Current & Future Analysis for Point-of-Care Glucose Testing by Product - Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Spain Historic Review for Point-of-Care Glucose Testing by Product - Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: Spain 15-Year Perspective for Point-of-Care Glucose Testing by Product - Percentage Breakdown of Value Sales for Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 65: Russia Recent Past, Current & Future Analysis for Point-of-Care Glucose Testing by Product - Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Russia Historic Review for Point-of-Care Glucose Testing by Product - Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: Russia 15-Year Perspective for Point-of-Care Glucose Testing by Product - Percentage Breakdown of Value Sales for Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 68: Rest of Europe Recent Past, Current & Future Analysis for Point-of-Care Glucose Testing by Product - Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Rest of Europe Historic Review for Point-of-Care Glucose Testing by Product - Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: Rest of Europe 15-Year Perspective for Point-of-Care Glucose Testing by Product - Percentage Breakdown of Value Sales for Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Point-of-Care Glucose Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 71: Asia-Pacific Recent Past, Current & Future Analysis for Point-of-Care Glucose Testing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 72: Asia-Pacific Historic Review for Point-of-Care Glucose Testing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: Asia-Pacific 15-Year Perspective for Point-of-Care Glucose Testing by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 74: Asia-Pacific Recent Past, Current & Future Analysis for Point-of-Care Glucose Testing by Product - Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Asia-Pacific Historic Review for Point-of-Care Glucose Testing by Product - Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: Asia-Pacific 15-Year Perspective for Point-of-Care Glucose Testing by Product - Percentage Breakdown of Value Sales for Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Point-of-Care Glucose Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 77: Australia Recent Past, Current & Future Analysis for Point-of-Care Glucose Testing by Product - Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Australia Historic Review for Point-of-Care Glucose Testing by Product - Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: Australia 15-Year Perspective for Point-of-Care Glucose Testing by Product - Percentage Breakdown of Value Sales for Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others for the Years 2015, 2025 & 2030
  • INDIA
    • Point-of-Care Glucose Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 80: India Recent Past, Current & Future Analysis for Point-of-Care Glucose Testing by Product - Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: India Historic Review for Point-of-Care Glucose Testing by Product - Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: India 15-Year Perspective for Point-of-Care Glucose Testing by Product - Percentage Breakdown of Value Sales for Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 83: South Korea Recent Past, Current & Future Analysis for Point-of-Care Glucose Testing by Product - Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: South Korea Historic Review for Point-of-Care Glucose Testing by Product - Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: South Korea 15-Year Perspective for Point-of-Care Glucose Testing by Product - Percentage Breakdown of Value Sales for Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 86: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Point-of-Care Glucose Testing by Product - Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Rest of Asia-Pacific Historic Review for Point-of-Care Glucose Testing by Product - Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: Rest of Asia-Pacific 15-Year Perspective for Point-of-Care Glucose Testing by Product - Percentage Breakdown of Value Sales for Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Point-of-Care Glucose Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 89: Latin America Recent Past, Current & Future Analysis for Point-of-Care Glucose Testing by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 90: Latin America Historic Review for Point-of-Care Glucose Testing by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: Latin America 15-Year Perspective for Point-of-Care Glucose Testing by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 92: Latin America Recent Past, Current & Future Analysis for Point-of-Care Glucose Testing by Product - Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Latin America Historic Review for Point-of-Care Glucose Testing by Product - Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: Latin America 15-Year Perspective for Point-of-Care Glucose Testing by Product - Percentage Breakdown of Value Sales for Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 95: Argentina Recent Past, Current & Future Analysis for Point-of-Care Glucose Testing by Product - Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Argentina Historic Review for Point-of-Care Glucose Testing by Product - Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: Argentina 15-Year Perspective for Point-of-Care Glucose Testing by Product - Percentage Breakdown of Value Sales for Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 98: Brazil Recent Past, Current & Future Analysis for Point-of-Care Glucose Testing by Product - Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Brazil Historic Review for Point-of-Care Glucose Testing by Product - Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: Brazil 15-Year Perspective for Point-of-Care Glucose Testing by Product - Percentage Breakdown of Value Sales for Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 101: Mexico Recent Past, Current & Future Analysis for Point-of-Care Glucose Testing by Product - Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Mexico Historic Review for Point-of-Care Glucose Testing by Product - Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: Mexico 15-Year Perspective for Point-of-Care Glucose Testing by Product - Percentage Breakdown of Value Sales for Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 104: Rest of Latin America Recent Past, Current & Future Analysis for Point-of-Care Glucose Testing by Product - Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Rest of Latin America Historic Review for Point-of-Care Glucose Testing by Product - Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: Rest of Latin America 15-Year Perspective for Point-of-Care Glucose Testing by Product - Percentage Breakdown of Value Sales for Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Point-of-Care Glucose Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 107: Middle East Recent Past, Current & Future Analysis for Point-of-Care Glucose Testing by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 108: Middle East Historic Review for Point-of-Care Glucose Testing by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 109: Middle East 15-Year Perspective for Point-of-Care Glucose Testing by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 110: Middle East Recent Past, Current & Future Analysis for Point-of-Care Glucose Testing by Product - Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Middle East Historic Review for Point-of-Care Glucose Testing by Product - Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 112: Middle East 15-Year Perspective for Point-of-Care Glucose Testing by Product - Percentage Breakdown of Value Sales for Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 113: Iran Recent Past, Current & Future Analysis for Point-of-Care Glucose Testing by Product - Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Iran Historic Review for Point-of-Care Glucose Testing by Product - Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 115: Iran 15-Year Perspective for Point-of-Care Glucose Testing by Product - Percentage Breakdown of Value Sales for Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 116: Israel Recent Past, Current & Future Analysis for Point-of-Care Glucose Testing by Product - Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Israel Historic Review for Point-of-Care Glucose Testing by Product - Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 118: Israel 15-Year Perspective for Point-of-Care Glucose Testing by Product - Percentage Breakdown of Value Sales for Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 119: Saudi Arabia Recent Past, Current & Future Analysis for Point-of-Care Glucose Testing by Product - Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Saudi Arabia Historic Review for Point-of-Care Glucose Testing by Product - Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 121: Saudi Arabia 15-Year Perspective for Point-of-Care Glucose Testing by Product - Percentage Breakdown of Value Sales for Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 122: UAE Recent Past, Current & Future Analysis for Point-of-Care Glucose Testing by Product - Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: UAE Historic Review for Point-of-Care Glucose Testing by Product - Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 124: UAE 15-Year Perspective for Point-of-Care Glucose Testing by Product - Percentage Breakdown of Value Sales for Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 125: Rest of Middle East Recent Past, Current & Future Analysis for Point-of-Care Glucose Testing by Product - Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Rest of Middle East Historic Review for Point-of-Care Glucose Testing by Product - Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 127: Rest of Middle East 15-Year Perspective for Point-of-Care Glucose Testing by Product - Percentage Breakdown of Value Sales for Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others for the Years 2015, 2025 & 2030
  • AFRICA
    • Point-of-Care Glucose Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 128: Africa Recent Past, Current & Future Analysis for Point-of-Care Glucose Testing by Product - Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Africa Historic Review for Point-of-Care Glucose Testing by Product - Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 130: Africa 15-Year Perspective for Point-of-Care Glucose Testing by Product - Percentage Breakdown of Value Sales for Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip and Others for the Years 2015, 2025 & 2030

IV. COMPETITION